None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with stage III periodontitis 2. Site selected having probing pocket depth of more than or equal to 6mm and Clinical attachment level of more than or equal to 5mm. 3. Age group 25 to 65 years.
Exclusion criteria
Exclusion criteria: 1. Patients with medical disorders such as cardiovascular or renal disease, poorly controlled diabetes, liver diseases, malignancy, and radiotherapy. 2. Patients with recent history or presence of acute or chronic infection. 3. Pregnant women or lactating mothers. 4. Inability of the persons to co-operate because of their physical or mental status or daily routine. 5. Patients who has gone under any antibiotic therapy in previous 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. To evaluate an effectiveness of gold and silver nanoparticles infused gel on salivary cortisol levels. 2. To evaluate an effectiveness of lycopene gel on salivary cortisol levels. 3. To evaluate an effectiveness of SRP alone on salivary cortisol levels. 4. To compare effectiveness of gold and silver nanoparticles infused gel, lycopene gel and SRP alone on salivary cortisol levelTimepoint: At baseline, 3 months and 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To evaluate an effectiveness of gold & silver nanoparticles infused gel on Plaque Index, Gingival Index, Probing Pocket Depth & Clinical Attachment Levels. 2. To evaluate an effectiveness of lycopene gel on Plaque Index, Gingival Index, Probing Pocket Depth & Clinical Attachment Levels. 3. To evaluate an effectiveness of SRP alone on Plaque Index, Gingival Index, Probing Pocket Depth & Clinical Attachment Levels. 4. To compare effectiveness of gold & silver nanoparticles infused gel, lycopene gel and SRP alone on Plaque Index, Gingival Index, Probing Pocket Depth & Clinical Attachment Levels.Timepoint: At baseline, 3 months & 6 months | — |
Countries
India
Contacts
PhD guide